Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

nal Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's RSV vaccine program.  This grant will be used to further advance the novel pediatric RSV vaccine.
 
  • Promising data were presented on GenVec's RSV vaccine program at the 8th Annual International Respiratory Syncytial Virus Symposium, demonstrating that GenVec's pre-clinical, universal RSV vaccine candidate is highly immunogenic and produces durable and broad protection from a single intramuscular administration.  Protection in cotton rat and mouse models was characterized by functional RSV neutralizing antibodies and no disease potentiation was observed.
     
  • Encouraging preclinical proof of concept data generated in non-human primates involving GenVec's RSV vaccine program were presented at the Keystone Symposia 2012 Meeting on Viral Immunity and Host Gene Influence.  GenVec's vaccine technology induced neutralizing antibody and significant T-cell responses with a single administration.  The immune responses were consistent with protective responses without disease potentiation, and multiple administrations increased the neutralizing antibody responses.
  • HSV Vaccine

  • GenVec conducted a successful pre-IND interaction with the U.S. Food and Drug Administration (FDA) to obtain guidance on the development plan for its vaccine against herpes simplex virus (HSV).  The outcome of the pre-IND interaction was obtaining clarification on the nonclinical, clinical, and chemistry, manufacturing, and control (CMC) requirements that need to be met in order to submit an acceptable IND.
  • Data were presented on GenVec's HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination.  The Company disclosed that a single administration of its genetic vaccine was effective against HSV2 in two industry-accepted HSV disease models.
  • Mala
    '/>"/>

    SOURCE GenVec, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
    2. GenVec Appoints Cynthia Collins as President and CEO
    3. GenVec Reports Inducement Award
    4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
    5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
    6. GenVec Reports Second Quarter 2012 Financial Results
    7. GenVec Reports Third Quarter 2012 Financial Results
    8. GenVec to Present at 25th Annual ROTH Conference
    9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
    10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... , Dec. 17, 2014  Northstar Global ... Depository Trust Company (DTC) has made their final ... Chill on the Company,s stock effective December 15, ... common stock for depository and book entry transfer ... Company is now once again fully "DTC Eligible", ...
    (Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, Inc. ... music products, today announced that it has signed ... manufacturer and supplier of innovative prosthetic, orthotic and ... part of the agreement, RSL Steeper will promote ... specifically configured for use within UK residential care ...
    (Date:12/17/2014)... LOS ANGELES , Dec. 17, 2014 /PRNewswire/ ... that the US Patent and Trademark Office (USPTO) ... candidate ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting ... glioblastoma. The claims of US Patent No. 8,871,211, ... treating neural cancer by administering a dendritic cell ...
    Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
    ... Inc. (NYSE: LDR ), a recognized leader ... and high quality medical consumable accessories, today reported financial results ... Fiscal 2012 Second Quarter Highlights ... prior year period. , Gross profit grew 11 percent ...
    ... Inc. (NASDAQ: UPI ), a medical device ... for the treatment of voiding dysfunctions, announced today that ... President and CFO, will present the Company,s business strategy ... JMP Securities Research Conference at 12:30 pm PT on Monday, ...
    Cached Medicine Technology:Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 2Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 3Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 4Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 5Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 6Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 7Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 8Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 9Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 10Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 11Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 12Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 13Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 14Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 15Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 16Landauer, Inc. Reports Fiscal 2012 Second Quarter Results 17Uroplasty to Present at the 11th Annual JMP Securities Research Conference 2
    (Date:12/21/2014)... Parker & Sons, Inc. a market leader ... other similar home contractor services announces a record number ... expert contracting services. The company is considered by many ... Arizona for well over 40 years. Parker and Sons ... quality customer service to the residents and business owners ...
    (Date:12/21/2014)... 2014 As testosterone therapy lawsuit ... stroke and blood clots from using testosterone products such ... study shows that the male hormone testosterone may increase ... study published in the Proceedings of the National Academy ... a group of male rats with naturally occurring colon ...
    (Date:12/20/2014)... BambooIndustry.com is a professional company offering many kinds ... shown its new engineered bamboo flooring collection, and announced ... , BambooIndustry.com’s customers come from many countries in the ... the CEO of the company, the global bamboo flooring ... few years, and the demand for eco-friendly bamboo flooring ...
    (Date:12/20/2014)... An improving macroeconomic landscape and a ... Massage Services industry over the five years ... the anticipated 1.0% annualized increase in per capita disposable ... the means to afford additional massages. “While the share ... a given year has declined from 2009 to 2012, ...
    (Date:12/20/2014)... holidays can be anything but joyous for people with ... and other allergy triggers. "The dust from the ... away in dank basements or dusty attics is triggering ... Shah, an affiliate faculty member at Loyola University Chicago ... Shah, who is also an allergist at Gottlieb ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Holiday Trimmings Can Trigger Allergies 2
    ... of Hopkins found a new study shows some cancer ... benefit from treatment with the drug, interferon.,Past research has ... some B-cell non-Hodgkin's lymphoma's. //A patient with both of ... The patient responded causing researchers in Paris to study ...
    ... Researchers studied that, babies born to women with high levels ... developmental problems as babies exposed to lead from sources like ... journal Pediatrics, they said this type of lead exposure// “may ... long residence time of lead in bone.” ,The findings ...
    ... medications can reduce abdominal fat in people with type 2 ... into the effect that the drug Pioglitazone has on people ... condition, who took the drug for 16 weeks. ,After ... measurements revealed an interesting redistribution of body fat, inspite of ...
    ... people who are at high risk of suffering a stroke, ... to be used by opticians and GPs to mass-screen patients.Strokes ... damaged blood vessels. Drugs that are effective at preventing stroke ... identify people with changes to their network of blood vessels ...
    ... protective substances, produced by the body in stressful situations ... researchers in the UK report. According to a report ... these heat-shock proteins, which are special proteins produced by ... the immune system of the body. ,In the ...
    ... University of Texas, have looked at data for treatment of ... with a stroke caused by bleeding into the brain do ... a blood vessel bursts within the blood supply surrounding the ... ,Data on nearly 10,000 patients admitted to 300 ...
    Cached Medicine News:
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: